Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics AMRN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Amarin Corporation PLC

AMRN
Current price
17.32 USD +0.03 USD (+0.17%)
Last closed 17.33 USD
ISIN US0231114044
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NASDAQ
Capitalization 346 428 096 USD
Yield for 12 month +2 222.34 %
1Y
3Y
5Y
10Y
15Y
AMRN
21.11.2021 - 28.11.2021

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland. Address: One Central Plaza, Dublin 2, Ireland, D02 K7K5

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.50 USD

P/E Ratio

Dividend Yield

Financials AMRN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+228 614 000 USD

Last Year

+306 911 000 USD

Current Quarter

+42 017 000 USD

Last Quarter

+62 306 000 USD

Current Year

+81 382 000 USD

Last Year

+165 541 000 USD

Current Quarter

+25 130 000 USD

Last Quarter

-9 567 000 USD
EBITDA -55 514 000 USD
Operating Margin TTM -39.88 %
Price to Earnings
Return On Assets TTM -5.06 %
PEG Ratio -1.74
Return On Equity TTM -17.25 %
Wall Street Target Price 10.50 USD
Revenue TTM 214 112 000 USD
Book Value 22.86 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -25.70 %
Dividend Yield
Gross Profit TTM 111 082 000 USD
Earnings per share -4.40 USD
Diluted Eps TTM -4.40 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -94.20 %
Profit Margin -41.07 %

Stock Valuation AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 500.00
Enterprise Value Revenue 0.34
Price Sales TTM 1.62
Enterprise Value EBITDA -5.80
Price Book MRQ 0.73

Technical Indicators AMRN

For 52 Weeks

7.08 USD 17.18 USD
50 Day MA 12.23 USD
Shares Short Prior Month 499 034
200 Day MA 10.98 USD
Short Ratio 4.66
Shares Short 430 048
Short Percent 3.03 %